Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Z2. COVID-19 Infection prevention

Session: Late Breaker Abstracts: COVID-19 Treatment & Prophylaxis

LB5 - PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults

Thursday, September 30, 2021
6:15 PM - 6:30 PM EDT
Participants should be aware of the following financial/non-financial relationships:
Myron J. Levin, MD: GSK group of companies (Employee, Research Grant or Support)
Andrew Ustianowski, MBBS: Vir/GlaxoSmithKline (Advisor or Review Panel member)
Stéphane De Wit, MD: Gilead (Grant/Research Support)Janssen (Grant/Research Support)Merck Sharpe & Dohme (Grant/Research Support)ViiV Healthcare (Grant/Research Support)
Odile Launay, MD, PhD: AstraZeneca (Grant/Research Support)GlaxoSmithKline (Consultant, Grant/Research Support, Other Financial or Material Support, Data safety monitoring board)Johnson & Johnson (Consultant, Grant/Research Support)Moderna (Consultant)Pfizer (Consultant, Grant/Research Support)Sanofi Pasteur (Consultant, Grant/Research Support)
Miles Avila, MPH, GStat: AstraZeneca (Employee, Shareholder)
Seth Seegobin, PhD: AstraZeneca (Employee, Shareholder)
Alison Templeton, PhD: AstraZeneca (Employee, Shareholder)
Yuan Yuan, PhD: AstraZeneca (Employee, Shareholder)
Philip Ambery, FRCP: AstraZeneca (Employee, Shareholder)
Rosalinda H. Arends, PhD: AstraZeneca (Employee, Shareholder)
Rohini Beavon, PhD: AstraZeneca (Employee, Shareholder)
Karen A. Near, MD: AstraZeneca (Employee, Shareholder)
Kelly W. Padilla, PharmD: AstraZeneca (Employee, Shareholder)
Konstantina Psachoulia, PhD: AstraZeneca (Employee, Shareholder)
Audrey Sharbaugh, PhD: AstraZeneca (Employee, Shareholder)
Katie Streicher, PhD: AstraZeneca (Employee, Shareholder)
Menelas N. Pangalos, PhD: AstraZeneca (Employee, Shareholder)
Mark T. Esser, PhD: AstraZeneca (Employee, Shareholder)
Robert A. Gasser, Jr., MD: AstraZeneca (Employee, Shareholder)

    Presenting Author(s)

  • ML

    Myron J. Levin, MD

    Professor
    University of Colorado Anschutz Medical Campus
    Aurora, CO, United States

    GSK group of companies (Employee, Research Grant or Support)

    • Co-Author(s)

  • AU

    Andrew Ustianowski, MBBS

    North Manchester General Hospital
    Manchester, England, United Kingdom

    Vir/GlaxoSmithKline (Advisor or Review Panel member)

  • SD

    Stéphane De Wit, MD

    CHU St-Pierre
    Brussels, Brussels Hoofdstedelijk Gewest, Belgium

    Gilead (Grant/Research Support)Janssen (Grant/Research Support)Merck Sharpe & Dohme (Grant/Research Support)ViiV Healthcare (Grant/Research Support)

  • OL

    Odile Launay, MD, PhD

    Université de Paris, Inserm F-CRIN I-REIVAC
    Paris, Ile-de-France, France

    AstraZeneca (Grant/Research Support)GlaxoSmithKline (Consultant, Grant/Research Support, Other Financial or Material Support, Data safety monitoring board)Johnson & Johnson (Consultant, Grant/Research Support)Moderna (Consultant)Pfizer (Consultant, Grant/Research Support)Sanofi Pasteur (Consultant, Grant/Research Support)

  • MA

    Miles Avila, MPH, GStat

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • SS

    Seth Seegobin, PhD

    AstraZeneca
    Cambridge, England, United Kingdom

    AstraZeneca (Employee, Shareholder)

  • AT

    Alison Templeton, PhD

    AstraZeneca
    Cambridge, England, United Kingdom

    AstraZeneca (Employee, Shareholder)

  • YY

    Yuan Yuan, PhD

    AstraZeneca, Gaithersburg, MD, USA
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • PA

    Philip Ambery, FRCP

    AstraZeneca
    Gothenburg, Vastra Gotaland, Sweden

    AstraZeneca (Employee, Shareholder)

  • RA

    Rosalinda H. Arends, PhD

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • RB

    Rohini Beavon, PhD

    AstraZeneca
    Cambridge, England, United Kingdom

    AstraZeneca (Employee, Shareholder)

  • KN

    Karen A. Near, MD

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • KP

    Kelly W. Padilla, PharmD

    AstraZeneca
    Durham, North Carolina, United States

    AstraZeneca (Employee, Shareholder)

  • KP

    Konstantina Psachoulia, PhD

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • AS

    Audrey Sharbaugh, PhD

    AstraZeneca
    Durham, North Carolina, United States

    AstraZeneca (Employee, Shareholder)

  • KS

    Katie Streicher, PhD

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • MP

    Menelas N. Pangalos, PhD

    AstraZeneca
    Cambridge, England, United Kingdom

    AstraZeneca (Employee, Shareholder)

  • ME

    Mark T. Esser, PhD

    Phylogenetic and alpha toxin variant analyses of Staphylococcus aureus strains isolated from patient
    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)

  • RG

    Robert A. Gasser, Jr., MD

    AstraZeneca
    Gaithersburg, Maryland, United States

    AstraZeneca (Employee, Shareholder)